Latigo Biotherapeutics Appoints Tim Lugo as Chief Financial Officer and Adds Beth Seidenberg and Jim Tananbaum to Board of Directors
Former William Blair partner and group head, Lugo has facilitated raising more than $6 billion in capital through 40-plus transactions, including IPOsVeteran venture capitalists Drs. Seidenberg and Tananbaum will help scale and accelerate the development of Latigo’s pipeline of non-opioid…